Metropolis Healthcare share hit a 52-week high of ₹574.45, surging 14 per cent in trade. Thyrocare soared 12 per cent to ₹526.10, while Vijaya Diagnostic Centre gained 7 per cent to ₹1,298.45.
Sector to outshine healthcare peers as higher volumes, steady realisations will boost revenue and profit, say analysts
In a video-interview with Sohini Das, Surendran Chemmenkotil, Managing Director of Metropolis Healthcare, speaks about the company's FY27 network expansion strategy
India's second-largest pathology chain reported strong year-on-year profit growth in the December quarter, supported by higher test volumes, preventive care demand and specialised diagnostics
Metropolis Healthcare shares rose 6 per cent it reported a 26 per cent Y-o-Y jump in its standalone revenue in the third quarter of the current financial year